Nomic
About:
Nomic develops a proteomic technology platform to understand, detect, and treat diseases with DNA nanotechnology.
Website: https://nomic.bio
Twitter/X: nomicbio
Top Investors: Y Combinator, Creative Destruction Lab (CDL), Lux Capital, Centech, SR One
Description:
Nomic is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. They are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and at high throughput. They offer scientists protein profiling solutions to empower them to decide the scope and scale of their experiments.
$60M
$1M to $10M
Montréal, Quebec, Canada
2017-01-01
hello(AT)nomic.bio
Arya Tavakoli, David Juncker, Jeff Munzar, Milad Dagher
11-50
2024-09-17
Private
© 2025 bioDAO.ai